Page last updated: 2024-08-21

alpha-aminopyridine and tiotropium bromide

alpha-aminopyridine has been researched along with tiotropium bromide in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	9 (90.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brose, M; Bundschuh, DS; Calverley, PM; Fabbri, LM; Izquierdo-Alonso, JL; Martinez, FJ; Rabe, KF	1
Conti, AA; Dilaghi, B; Modesti, PA; Nozzoli, C	1
Izquierdo Alonso, JL	2
Banerjee, R; Cheng, D; Marynchenko, M; Mocarski, M; Sun, SX; Wu, EQ; Yin, D; Yu, AP	1
Lundquist, LM; Metzger, NL	1
Chou, A; D'Urzo, AD	1
Domvri, K; Hatzizisi, O; Kikidaki, V; Kioumis, I; Lampaki, S; Liaka, A; Organtzis, J; Papaioannou, A; Petridis, D; Porpodis, K; Tsirgogianni, K; Zarogoulidis, K; Zarogoulidis, P	1
Calverley, P; Celli, BR; Chambers, M; Clark, JF; Hawkins, N; Scott, DA; Thompson, JC; Woods, B	1

Reviews

5 review(s) available for alpha-aminopyridine and tiotropium bromide

Article	Year
[Clinical profile of roflumilast]. Archivos de bronconeumologia, 2010, Volume: 46 Suppl 10 Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Forced Expiratory Volume; Humans; Mice; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Rats; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Weight Loss	2010
[Phosphodiesterase-4 inhibitors: roflumilast]. Revista clinica espanola, 2011, Volume: 211 Suppl 2 Topics: Adrenergic beta-2 Receptor Agonists; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Humans; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives; Tiotropium Bromide	2011
A review of the advances in chronic obstructive pulmonary disease treatment. Journal of pharmacy practice, 2012, Volume: 25, Issue:6 Topics: Aminopyridines; Benzamides; Bronchodilator Agents; Cyclopropanes; Humans; Indans; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Randomized Controlled Trials as Topic; Scopolamine Derivatives; Tiotropium Bromide	2012
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC pulmonary medicine, 2015, Nov-11, Volume: 15 Topics: Albuterol; Aminopyridines; Beclomethasone; Benzamides; Benzyl Alcohols; Bronchodilator Agents; Budesonide; Chlorobenzenes; Cyclopropanes; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Ipratropium; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Survival Rate; Theophylline; Tiotropium Bromide; Triamcinolone	2015
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms. Prescrire international, 2016, Volume: 25, Issue:176 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Bronchodilator Agents; Budesonide; Cyclopropanes; Fluticasone; Formoterol Fumarate; Humans; Ipratropium; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Recurrence; Salmeterol Xinafoate; Theophylline; Tiotropium Bromide	2016

Trials

1 trial(s) available for alpha-aminopyridine and tiotropium bromide

Article	Year
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet (London, England), 2009, Aug-29, Volume: 374, Issue:9691 Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Aminopyridines; Analysis of Variance; Benzamides; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Regression Analysis; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Smoking; Tiotropium Bromide; Treatment Outcome; Vital Capacity	2009

Article

Year

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

Lancet (London, England), 2009, Aug-29, Volume: 374, Issue:9691

Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Aminopyridines; Analysis of Variance; Benzamides; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Regression Analysis; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Smoking; Tiotropium Bromide; Treatment Outcome; Vital Capacity

2009

Other Studies

4 other study(ies) available for alpha-aminopyridine and tiotropium bromide

Article	Year
New evidence in pulmonary and preventive medicine. Internal and emergency medicine, 2010, Volume: 5, Issue:2 Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Benzamides; Breast Neoplasms; Bronchodilator Agents; Cyclopropanes; Disease Progression; Early Detection of Cancer; Evidence-Based Medicine; Female; Humans; Papillomavirus Vaccines; Preventive Medicine; Primary Prevention; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Secondary Prevention; Tiotropium Bromide; Uterine Cervical Neoplasms	2010
Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD. Journal of medical economics, 2011, Volume: 14, Issue:6 Topics: Aminopyridines; Benzamides; Bronchodilator Agents; Cost-Benefit Analysis; Cyclopropanes; Drug Combinations; Health Services; Health Status; Humans; Markov Chains; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Reproducibility of Results; Scopolamine Derivatives; Severity of Illness Index; Time Factors; Tiotropium Bromide	2011
New therapy for managing moderate to severe chronic obstructive pulmonary disease. Canadian family physician Medecin de famille canadien, 2014, Volume: 60, Issue:4 Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Aminopyridines; Benzamides; Bronchodilator Agents; Cyclopropanes; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Multicenter Studies as Topic; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Tiotropium Bromide	2014
Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients. International journal of chronic obstructive pulmonary disease, 2015, Volume: 10 Topics: Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Flow Cytometry; Fluticasone; Forced Expiratory Volume; Greece; Humans; Lung; Muscarinic Antagonists; Phagocytosis; Phosphodiesterase 4 Inhibitors; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Salmeterol Xinafoate; Spirometry; Time Factors; Tiotropium Bromide; Treatment Outcome; Vital Capacity	2015